Judicial Panel To Consider Acthar Gel MDL At May 27 Hearing

Mealey's (April 16, 2021, 1:14 PM EDT) -- WASHINGTON, D.C. — A May 27 hearing by a federal judicial panel was scheduled April 15 on whether to centralize 10 federal lawsuits alleging that drug maker Mallinckrodt ARD LLC and pharmacy benefit manager Express Scripts violated antitrust, racketeering and consumer fraud law in the sale and distribution of the specialty drug Acthar....